+65 63464191 info@healthytimes.com.sg
Health Magazine Singapore l Singapore Health Magazine l Healthy Times Magazine
  • Home
  • Health
  • Fitness
  • Beauty
  • Food & Nutrition
  • Green Living
  • Kids & Women
  • Disease and Prevention
  • Well Being
  • Events
  • Bahasa
Select Page

Daesang to Showcase Global Food Leadership at THAIFEX-Anuga Asia 2026

by | PRNewswire Asia

SEOUL, South Korea, May 18, 2026 /PRNewswire/ — Daesang announced its participation in THAIFEX-Anuga Asia 2026, Asia’s premier food trade exhibition, to be held in Bangkok from May 26 to 30 local time. Jointly organized by Thailand’s DITP, TCC, and...

LOTTE Biologics Expands Antibody Manufacturing Agreement with Ottimo Pharma

by | PRNewswire Asia

SEOUL, South Korea, May 18, 2026 /PRNewswire/ — LOTTE Biologics (Co-CEOs James Park and Yooyeol Shin) announce an expansion of its collaboration with Ottimo Pharma, an innovative biotech company developing one-of-a-kind PD-1/VEGFR2...

Eyes that photosynthesise: NUS scientists plant a cure for dry eye disease

by | PRNewswire Asia

A nanosized extract of the plant thylakoid grana — the molecular engine behind photosynthesis — is transplanted into the eye’s corneal cells, producing a key protective molecule when exposed to ambient light, opening a new front against dry eye disease...

Malaysia Healthcare Week Myanmar 2026 Opens in Yangon with Leading Hospitals Showcasing Specialised Care for Myanmar Patients

by | PRNewswire Asia

YANGON, Myanmar and KUALA LUMPUR, Malaysia, May 15, 2026 /PRNewswire/ — Malaysia Healthcare Week Yangon 2026 is officially launched today at Park Royal Yangon, bringing together leading Malaysian hospitals to connect directly with Myanmar patients,...

Moldova Celebrates 25 Years of National Wine Day, Strengthening Its Position as a Rising Global Wine Destination

by | PRNewswire Asia

CHIȘINĂU, Moldova, May 15, 2026 /PRNewswire/ — The Republic of Moldova will mark the 25th anniversary of National Wine Day under the slogan "United by Wine" on 3–4 October 2026 in Chișinău, celebrating a milestone that reflects the country’s...

Phase II Data from a Randomized Double-Blind Trial of Ligufalimab (Anti-CD47) Combination Therapy in Frontline AML Published at EHA 2026

by | PRNewswire Asia

HONG KONG, May 15, 2026 /PRNewswire/ — Akeso, Inc. (9926.HK) ("Akeso" or the "Company") today announced that compelling results from its randomized, double-blind, placebo-controlled Phase II trial (AK117-206) of ligufalimab (AK117) will be...
« Older Entries
Next Entries »
  • Beauty
  • Disease and Prevention
  • Events
  • Fitness
  • Food and Nutrition
  • Green Living
  • Health
  • Kids and Women
  • News
  • Well Being

PRNewswire Asia

Sitemap

Links

editor@healthytimes.com.sg

editor@healthytimes.com.sg (Press Release)

Phone:+65 63464191

  • Facebook
© Copyright healthytimes.com.sg